Evidence map›Paper›PMID 34203700›Full record

ArticleInternational journal of molecular sciences2021

Toxicity and Antioxidant Activity of Fullerenol C

Ekaterina S Kovel, Arina G Kicheeva, Natalia G Vnukova, Grigory N Churilov, Evsei A Stepin, Nadezhda S Kudryasheva

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 37 citations in OpenAlex.

  1. DFT Study of NO and NOMolecules (Basel, Switzerland) · 2026
    Article
  2. The fullerenol CJournal of bioenergetics and biomembranes · 2026
    Article
  3. Metallofullerenol ScAdvanced healthcare materials · 2026
    Article
  4. Study of fullerene CScientific reports · 2025
    Article
  5. Effect of Fullerenol CMolecules (Basel, Switzerland) · 2025
    Article
  6. Cytotoxicity of Fullerenol CDoklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections · 2025
    Article
  7. Review
  8. Article
  9. Fullerenol CAntioxidants (Basel, Switzerland) · 2024
    Article
  10. Article
  11. Article
  12. Water-Soluble Fullerene CMicroorganisms · 2023
    Article
  13. Article
  14. Polyhydroxylated Fullerene CJournal of inflammation research · 2023
    Article
  15. Marine Bacteria under Low-Intensity Radioactive Exposure: Model Experiments.International journal of molecular sciences · 2022
    Review
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Ekaterina S KovelInstitute of Biophysics SB RAS, FRC KSC SB RAS, 660036 Krasnoyarsk, Russia.ORCID 0000-0002-4524-6413
Arina G KicheevaFRC KSC SB RAS, 660036 Krasnoyarsk, Russia.
Natalia G VnukovaInstitute of Physics SB RAS, FRC KSC SB RAS, 660036 Krasnoyarsk, Russia.
Grigory N ChurilovInstitute of Physics SB RAS, FRC KSC SB RAS, 660036 Krasnoyarsk, Russia.ORCID 0000-0003-2889-490X
Evsei A StepinInstitute of Fundamental Biology and Biotechnology, Siberian Federal University, 660041 Krasnoyarsk, Russia.
Nadezhda S KudryashevaInstitute of Biophysics SB RAS, FRC KSC SB RAS, 660036 Krasnoyarsk, Russia.ORCID 0000-0001-5315-8002
Institute of Biophysics · RUInstitute of Physics · RUKrasnoyarsk Scientific Center · RUSiberian Federal University · RU

Funding

Program of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing Fundamental Study 2020-2025 (Russian Federation)Russian Foundation for Basic Research N18-29-19003Russian Foundation for Basic Research, Krasnoyarsk Territory and Krasnoyarsk Regional Fund of Science N20-44-243001
6 · The paper itself

Abstract

Fullerene is a nanosized carbon structure with potential drug delivery applications. We studied the bioeffects of a water-soluble fullerene derivative, fullerenol, with 10-12 oxygen groups (F10-12); its structure was characterized by IR and XPS spectroscopy. A bioluminescent enzyme system was used to study toxic and antioxidant effects of F10-12 at the enzymatic level. Antioxidant characteristics of F10-12 were revealed in model solutions of organic and inorganic oxidizers. Low-concentration activation of bioluminescence was validated statistically in oxidizer solutions. Toxic and antioxidant characteristics of F10-12 were compared to those of homologous fullerenols with a higher number of oxygen groups:F24-28 and F40-42. No simple dependency was found between the toxic/antioxidant characteristics and the number of oxygen groups on the fullerene's carbon cage. Lower toxicity and higher antioxidant activity of F24-28 were identified and presumptively attributed to its higher solubility. An active role of reactive oxygen species (ROS) in the bioeffects of F10-12 was demonstrated. Correlations between toxic/antioxidant characteristics of F10-12 and ROS content were evaluated. Toxic and antioxidant effects were related to the decrease in ROS content in the enzyme solutions. Our results reveal a complexity of ROS effects in the enzymatic assay system.

Indexed as

AntioxidantsFullerenesKineticsLuminescenceOxidation-ReductionOxygenReactive Oxygen SpeciesAntioxidantsFullerenesfullerenolOxygenReactive Oxygen Speciesantioxidant activitybioluminescent assayfullerenolhormesisreactive oxygen speciestoxicity

Identifiers

PMID34203700
PMCPMC8232284
OpenAlexW3171141822

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.